載入...
Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future
Multiple Sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system (CNS) which affects over 2.5 million people worldwide. Although MS has been extensively studied, many challenges still remain in regards to treatment, diagnosis, and prognosis. Typically, prognosis and indivi...
Na minha lista:
| 發表在: | Expert Rev Clin Immunol |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4326231/ https://ncbi.nlm.nih.gov/pubmed/25523168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/1744666X.2015.991315 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|